Mechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721
- PMID: 25933104
- PMCID: PMC4416797
- DOI: 10.1371/journal.pone.0125727
Mechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721
Abstract
Arctigenin (ARG) has been previously reported to exert high biological activities including anti-inflammatory, antiviral and anticancer. In this study, the anti-tumor mechanism of ARG towards human hepatocellular carcinoma (HCC) was firstly investigated. We demonstrated that ARG could induce apoptosis in Hep G2 and SMMC7721 cells but not in normal hepatic cells, and its apoptotic effect on Hep G2 was stronger than that on SMMC7721. Furthermore, the following study showed that ARG treatment led to a loss in the mitochondrial out membrane potential, up-regulation of Bax, down-regulation of Bcl-2, a release of cytochrome c, caspase-9 and caspase-3 activation and a cleavage of poly (ADP-ribose) polymerase in both Hep G2 and SMMC7721 cells, suggesting ARG-induced apoptosis was associated with the mitochondria mediated pathway. Moreover, the activation of caspase-8 and the increased expression levels of Fas/FasL and TNF-α revealed that the Fas/FasL-related pathway was also involved in this process. Additionally, ARG induced apoptosis was accompanied by a deactivation of PI3K/p-Akt pathway, an accumulation of p53 protein and an inhibition of NF-κB nuclear translocation especially in Hep G2 cells, which might be the reason that Hep G2 was more sensitive than SMMC7721 cells to ARG treatment.
Conflict of interest statement
Figures
Similar articles
-
Regulation of Intrinsic and Extrinsic Apoptotic Pathways in Osteosarcoma Cells Following Oleandrin Treatment.Int J Mol Sci. 2016 Nov 23;17(11):1950. doi: 10.3390/ijms17111950. Int J Mol Sci. 2016. PMID: 27886059 Free PMC article.
-
Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways.Toxicol In Vitro. 2011 Aug;25(5):1027-32. doi: 10.1016/j.tiv.2011.03.023. Epub 2011 Apr 3. Toxicol In Vitro. 2011. PMID: 21466843
-
Furazolidone induces apoptosis through activating reactive oxygen species-dependent mitochondrial signaling pathway and suppressing PI3K/Akt signaling pathway in HepG2 cells.Food Chem Toxicol. 2015 Jan;75:173-86. doi: 10.1016/j.fct.2014.11.019. Epub 2014 Nov 27. Food Chem Toxicol. 2015. PMID: 25434308
-
Apoptosis: A Target for Anticancer Therapy.Int J Mol Sci. 2018 Feb 2;19(2):448. doi: 10.3390/ijms19020448. Int J Mol Sci. 2018. PMID: 29393886 Free PMC article. Review.
-
Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment.Eur J Pharmacol. 2021 Oct 15;909:174419. doi: 10.1016/j.ejphar.2021.174419. Epub 2021 Aug 12. Eur J Pharmacol. 2021. PMID: 34391770 Review.
Cited by
-
AMPK Activity: A Primary Target for Diabetes Prevention with Therapeutic Phytochemicals.Nutrients. 2021 Nov 12;13(11):4050. doi: 10.3390/nu13114050. Nutrients. 2021. PMID: 34836306 Free PMC article. Review.
-
A Traditional Chinese Medicine Herb Mixture Qingjie Fuzheng Granules Inhibits Hepatocellular Carcinoma Cells Growth by Inducing Apoptosis.J Evid Based Integr Med. 2018 Jan-Dec;23:2515690X18789632. doi: 10.1177/2515690X18789632. J Evid Based Integr Med. 2018. PMID: 30045633 Free PMC article.
-
Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.Front Pharmacol. 2018 Mar 27;9:268. doi: 10.3389/fphar.2018.00268. eCollection 2018. Front Pharmacol. 2018. PMID: 29636686 Free PMC article.
-
Arctigenin induces caspase-dependent apoptosis in FaDu human pharyngeal carcinoma cells.Korean J Physiol Pharmacol. 2022 Nov 1;26(6):447-456. doi: 10.4196/kjpp.2022.26.6.447. Korean J Physiol Pharmacol. 2022. PMID: 36302620 Free PMC article.
-
Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.Oncotarget. 2016 Apr 26;7(17):24339-47. doi: 10.18632/oncotarget.8248. Oncotarget. 2016. PMID: 27013579 Free PMC article.
References
-
- Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell. 2004; 5: 215–219. - PubMed
-
- El-Serag HB, Rudolph L. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132: 2557–2576. - PubMed
-
- Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nature reviews Cancer. 2006; 6: 674–687. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous